QQ客服 官方微博 反馈留言

	Genome-wide association study (GWAS) of pazopanib efficacy and safety in patients with ovarian cancer who have not progressed following first-line standard therapy.
	Scambia, Giovanni; Johnson, Toby; Floquet, Anne; Heitz, Florian; Park, Sang-Yoon; Buck, Martin; Gallego, Rafael A. F. Alvarez; Shimada, Muneaki; Vergote, Ignace; Avall-Lundqvist, Elisabeth
	2014
会议名称	JOURNAL OF CLINICAL ONCOLOGY
会议日期	2014-05-20
收录类别	CPCI-S
URL标识	查看原文
内容类型	会议论文
URI标识	http://www.corc.org.cn/handle/1471x/6671545
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Scambia, Giovanni,Johnson, Toby,Floquet, Anne,et al. Genome-wide association study (GWAS) of pazopanib efficacy and safety in patients with ovarian cancer who have not progressed following first-line standard therapy.[C]. 见:JOURNAL OF CLINICAL ONCOLOGY. 2014-05-20.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。